These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 19283339)

  • 1. Design of compound libraries for fragment screening.
    Blomberg N; Cosgrove DA; Kenny PW; Kolmodin K
    J Comput Aided Mol Des; 2009 Aug; 23(8):513-25. PubMed ID: 19283339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual fragment screening: an exploration of various docking and scoring protocols for fragments using Glide.
    Kawatkar S; Wang H; Czerminski R; Joseph-McCarthy D
    J Comput Aided Mol Des; 2009 Aug; 23(8):527-39. PubMed ID: 19495993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometry for fragment screening.
    Chan DS; Whitehouse AJ; Coyne AG; Abell C
    Essays Biochem; 2017 Nov; 61(5):465-473. PubMed ID: 28986384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and NMR validation of minimal pharmacophore hypotheses for the generation of fragment libraries enriched in heparanase inhibitors.
    Gozalbes R; Mosulén S; Carbajo RJ; Pineda-Lucena A
    J Comput Aided Mol Des; 2009 Aug; 23(8):555-69. PubMed ID: 19421720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening Ligands by X-ray crystallography.
    Davies DR
    Methods Mol Biol; 2014; 1140():315-23. PubMed ID: 24590727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists.
    Wu B; Barile E; De SK; Wei J; Purves A; Pellecchia M
    Curr Top Med Chem; 2015; 15(20):2032-42. PubMed ID: 25986689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons for fragment library design: analysis of output from multiple screening campaigns.
    Chen IJ; Hubbard RE
    J Comput Aided Mol Des; 2009 Aug; 23(8):603-20. PubMed ID: 19495994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragment-Based Ligand Designing.
    Katiyar SP; Malik V; Kumari A; Singh K; Sundar D
    Methods Mol Biol; 2018; 1762():123-144. PubMed ID: 29594771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTS by NMR of combinatorial libraries: a fragment-based approach to ligand discovery.
    Wu B; Zhang Z; Noberini R; Barile E; Giulianotti M; Pinilla C; Houghten RA; Pasquale EB; Pellecchia M
    Chem Biol; 2013 Jan; 20(1):19-33. PubMed ID: 23352136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multiple roles of computational chemistry in fragment-based drug design.
    Law R; Barker O; Barker JJ; Hesterkamp T; Godemann R; Andersen O; Fryatt T; Courtney S; Hallett D; Whittaker M
    J Comput Aided Mol Des; 2009 Aug; 23(8):459-73. PubMed ID: 19533374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragment-based drug discovery and its application to challenging drug targets.
    Price AJ; Howard S; Cons BD
    Essays Biochem; 2017 Nov; 61(5):475-484. PubMed ID: 29118094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in the fragment-based drug discovery].
    Ren J; Li J; Shi F; Wang X; He JH; Xu YC; Zhang NX; Xiong B; Shen JK
    Yao Xue Xue Bao; 2013 Jan; 48(1):14-24. PubMed ID: 23600136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragment-based drug discovery.
    Warr WA
    J Comput Aided Mol Des; 2009 Aug; 23(8):453-8. PubMed ID: 19554264
    [No Abstract]   [Full Text] [Related]  

  • 14. Fragment-based approaches and computer-aided drug discovery.
    Rognan D
    Top Curr Chem; 2012; 317():201-22. PubMed ID: 21710380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive combinatorial design of focused compound libraries.
    Schneider G; Schüller A
    Methods Mol Biol; 2009; 572():135-47. PubMed ID: 20694689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragment-based lead discovery and design.
    Joseph-McCarthy D; Campbell AJ; Kern G; Moustakas D
    J Chem Inf Model; 2014 Mar; 54(3):693-704. PubMed ID: 24490951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Energetic analysis of fragment docking and application to structure-based pharmacophore hypothesis generation.
    Loving K; Salam NK; Sherman W
    J Comput Aided Mol Des; 2009 Aug; 23(8):541-54. PubMed ID: 19421721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent trends in library design: 'rational design' revisited.
    Schnur DM
    Curr Opin Drug Discov Devel; 2008 May; 11(3):375-80. PubMed ID: 18428091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein X-ray Crystallography and Drug Discovery.
    Maveyraud L; Mourey L
    Molecules; 2020 Feb; 25(5):. PubMed ID: 32106588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biophysical screening for the discovery of small-molecule ligands.
    Ciulli A
    Methods Mol Biol; 2013; 1008():357-88. PubMed ID: 23729259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.